According to Zacks, “HMS Holdings outperformed its industry in a year’s time. An upbeat guidance for 2019 is indicative of brighter prospects. At the Analytical Services segment, the company is likely to benefit from strong gains. Precisely, it expects double-digit growth in Analytical Services, which includes Payment Integrity, Medicare RAC, and Total Population Management and low-to-mid single-digit growth in COB unit. HMS Holdings is consistently improving margins and profitability on product-yield enhancements and process improvements. On the flip side, HMS Holdings has been witnessing sluggishness in the COB unit in recent times. Cutthroat competition in the U.S. medical cost containment space is an added concern. Further, the company looks a tad expensive.”
Other equities analysts also recently issued reports about the company. BidaskClub raised HMS from a hold rating to a buy rating in a research report on Thursday, February 7th. ValuEngine downgraded HMS from a strong-buy rating to a buy rating in a research report on Monday, December 17th. Cantor Fitzgerald reaffirmed a hold rating and issued a $34.00 target price on shares of HMS in a research report on Friday, February 22nd. Finally, William Blair reaffirmed an outperform rating on shares of HMS in a research report on Thursday, March 14th. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The company presently has an average rating of Buy and an average price target of $33.50.
NASDAQ HMSY opened at $28.70 on Friday. The stock has a market capitalization of $2.56 billion, a price-to-earnings ratio of 34.17, a PEG ratio of 2.82 and a beta of 1.62. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.40 and a quick ratio of 4.40. HMS has a 1-year low of $17.11 and a 1-year high of $38.15.
HMS (NASDAQ:HMSY) last released its earnings results on Friday, February 22nd. The business services provider reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.03. The company had revenue of $155.80 million during the quarter, compared to the consensus estimate of $155.84 million. HMS had a return on equity of 14.21% and a net margin of 9.19%. HMS’s revenue was up 4.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.24 EPS. On average, sell-side analysts forecast that HMS will post 0.97 earnings per share for the current fiscal year.
In other news, insider Meredith W. Bjorck sold 2,362 shares of the business’s stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $30.10, for a total transaction of $71,096.20. Following the completion of the transaction, the insider now directly owns 51,755 shares of the company’s stock, valued at $1,557,825.50. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Jeffrey Scott Sherman sold 268,426 shares of the business’s stock in a transaction dated Thursday, February 28th. The stock was sold at an average price of $34.55, for a total value of $9,274,118.30. Following the transaction, the chief financial officer now directly owns 218,253 shares of the company’s stock, valued at $7,540,641.15. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,018,795 shares of company stock valued at $35,023,853. Corporate insiders own 4.54% of the company’s stock.
Hedge funds have recently bought and sold shares of the stock. Oregon Public Employees Retirement Fund purchased a new stake in HMS during the fourth quarter worth approximately $32,000. We Are One Seven LLC purchased a new stake in HMS during the fourth quarter worth approximately $84,000. LS Investment Advisors LLC lifted its stake in HMS by 80.0% during the fourth quarter. LS Investment Advisors LLC now owns 5,016 shares of the business services provider’s stock worth $141,000 after purchasing an additional 2,230 shares during the last quarter. BlueMountain Capital Management LLC purchased a new stake in HMS during the third quarter worth approximately $146,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in HMS by 11.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,826 shares of the business services provider’s stock worth $164,000 after purchasing an additional 592 shares during the last quarter. Hedge funds and other institutional investors own 95.47% of the company’s stock.
HMS Company Profile
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions.
Recommended Story: Beta
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.